Krystal Biotech, Inc.KRYSNASDAQ

Revenue (LTM)

$389M

+33.9% YoY

Net Income (LTM)

$205M

+129.7% YoY

Free Cash Flow

$189M

Revenue CAGR (5Y)

—

—Marginsstable

FCF$0.2B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	51	291↑473.0%	389↑33.9%
Gross Profit	0	0	48	270↑468.1%	360↑33.2%
Operating Income	-68	-145↓112.7%	-110↑24.4%	66↑159.9%	161↑145.5%
Net Income	-70	-140↓101.2%	11↑107.8%	89↑715.6%	205↑129.7%
EBITDA	-66	-117↓76.4%	-91↑21.8%	110↑220.4%	168↑52.7%
EPS Diluted	-3.13	-5.49↓75.4%	0.39↑107.1%	3.00↑669.2%	6.84↑128.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	341	162↓52.6%	358↑121.3%	345↓3.8%	496↑43.9%
Total Current Assets	442	384↓13.2%	588↑53.2%	742↑26.2%	1,025↑38.1%
Total Assets	626	558↓10.8%	818↑46.5%	1,056↑29.0%	1,334↑26.3%
Total Current Liabilities	26	29↑12.1%	33↑14.7%	102↑208.2%	103↑0.9%
Total Liabilities	33	36↑10.7%	40↑9.6%	109↑175.6%	114↑4.4%
Total Equity	594	522↓12.0%	779↑49.1%	946↑21.5%	1,220↑28.9%
Total Debt	8	9↑11.3%	8↓9.4%	7↓10.3%	9↑28.6%
Net Debt	-333	-153↑54.1%	-350↓129.0%	-338↑3.6%	-487↓44.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-48	-101↓109.8%	-89↑11.7%	123↑239.0%	201↑62.7%
Capital Expenditure	-68	-53↑22.5%	-12↑77.7%	-4↑64.1%	-12↓182.0%
Free Cash Flow	-116	-154↓32.1%	-101↑34.5%	119↑218.5%	189↑58.5%
Stock-Based Comp	15	33↑116.9%	40↑20.2%	49↑23.0%	55↑11.0%
Net Change in Cash	73	-179↓345.8%	196↑209.5%	-13↓106.9%	151↑1224.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance